Comparison of the Effects of Albumin 5% versus Ringer's Lactate on Blood Loss and Coagulation after Vascular Surgery Using Thromboelastography by Mohamed, Ahmed Abdalla et al.
 _______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2019 Apr 30; 7(8):1335-1341.                                                                                                                                                   1335 
 
ID Design Press, Skopje, Republic of Macedonia 
Open Access Macedonian Journal of Medical Sciences. 2019 Apr 30; 7(8):1335-1341. 
https://doi.org/10.3889/oamjms.2019.263 
eISSN: 1857-9655 
Clinical Science 
 
 
  
 
Comparison of the Effects of Albumin 5% versus Ringer's 
Lactate on Blood Loss and Coagulation after Vascular Surgery 
Using Thromboelastography 
 
 
 
Ahmed Abdalla Mohamed
1*
, Nadia Gameel Elsharkawi
1
, Osama Ismail Zaid
1
, Ahmed Farag Mohamed
1
, Nashwa Nabeel 
Mohamed
1
, Michael Wahib Wadeed
1
, Adham Feteha Tawfik
2
, Amr Abdelmonam Abdelaziz Mostafa Elkatatny
3
 
 
1
Department of Anaesthesia and Critical Care Medicine, Cairo University, Cairo, Egypt; 
2
Students' Hospital, Cairo University, 
Cairo, Egypt; 
3
Faculty of Medicine, Cairo University, Cairo, Egypt 
 
Citation: Mohamed AA, Elsharkawi NG, Zaid OI, 
Mohamed AF, Mohamed NN, Wadeed MW, Tawfik AF, 
Elkatatny AAAM. Comparison of the Effects of Albumin 
5% versus Ringer's Lactate on Blood Loss and 
Coagulation after Vascular Surgery Using 
Thromboelastography. Open Access Maced J Med Sci. 
2019 Apr 30; 7(8):1335-1341. 
https://doi.org/10.3889/oamjms.2019.263 
Keywords: Albumin 5%; Ringer's lactate; Vascular 
surgery; Blood loss; Coagulation, Thromboelastography 
*Correspondence: Ahmed Abdalla Mohamed. 
Department of Anaesthesia and Critical Care Medicine, 
Cairo University, Cairo, Egypt. E-mail: 
ahmed.aboali7268@gmail.com 
Received: 08-Mar-2019; Revised: 07-Apr-2019; 
Accepted: 08-Apr-2019; Online first: 29-Apr-2019 
Copyright: © 2019 Ahmed Abdalla Mohamed, Nadia 
Gameel Elsharkawi, Osama Ismail Zaid, Ahmed Farag 
Mohamed, Nashwa Nabeel Mohamed, Michael Wahib 
Wadeed, Adham Feteha Tawfik, Amr Abdelmonam 
Abdelaziz Mostafa Elkatatny. This is an open-access 
article distributed under the terms of the Creative 
Commons Attribution-NonCommercial 4.0 International 
License (CC BY-NC 4.0) 
Funding: This research did not receive any financial 
support 
Competing Interests: The authors have declared that no 
competing interests exist 
 
 
 
 
 
Abstract 
AIM: Comparing the effects of Albumin 5% versus Ringer's lactate on blood loss and coagulation after vascular 
surgery using  
METHODS: In this randomised study, 60 patients, aged (18-60 years) ASA physical status (I-III) undergoing 
vascular surgery were included in the study and randomly allocated into two groups using a random number 
generator, to receive either Human albumin or Ringer lactate after obtaining written informed consent. Group A 
received 1-2 ml per minute of human albumin 5% combined with normal saline (0.9%). Group B received Ringer's 
lactate only as of the main solution. Variables were measured after administration of fluids as postoperative 
measures. The amount of blood needed for testing was 4 ml drawn before the operation and at the end of surgery 
with a citrate tube (blue tube) from the venous line or using a regular needle. The standard time of 15 minutes 
was considered to begin processing. 
RESULTS: There was no statistically significant difference observed between both groups regarding demographic 
data, surgical wound drainage, haemoglobin level, hematocrit level and coagulation profile. Regarding ROTEM 
thermoelectrometry variables showed that there was no statistically significant difference was found between the 
two groups In-TEM variables (Ex-TEM Clotting time, TEM Clot Formation Time) but In-TEM Alpha Angel 
measured in degrees showed a Statistically significant difference between the two groups. P < 0.001 and Ex-TEM 
Maximum Clotting Firmness MCF values measured in mm, there was a statistically significant difference between 
the two groups P = 0.045. 
CONCLUSION: This study concluded that the use of human albumin (5%) in vascular surgeries before reaching 
the trigger point for blood transfusion didn’t improve blood loss or coagulation profile compared to the use of 
ringer lactate only. Therefore, ringer lactate can be used as a good replacement for human albumin. Ringer 
lactate is readily available and inexpensive while human albumin may be costly. 
 
 
 
 
 
 
Introduction 
 
Anesthesiologists always seek for the 
optimum fluid to be used especially in bloody 
operations like vascular surgeries before reaching the 
trigger for blood transfusion, Crystalloids, in the form 
of Ringer's lactate (RL), or and colloids such as 5% 
human serum albumin (HA) are commonly used for 
intra-operative fluid management during surgery [1].
 
 
Monitoring perioperative coagulation 
competence has relied on clinical estimates besides 
on plasma coagulation tests [2]. Plasma coagulation 
tests were, however, introduced to evaluate the lack 
of coagulation factors and not to predict the risk of 
bleeding or for guiding hemostatic therapy [3].
 
 
In contrast, viscoelastic evaluation of whole 
blood enables rapid diagnosis of coagulation 
competence and may be displayed in real time within 
the operating theatre. Thus, the use of perioperative 
coagulation monitoring by, e.g. Thromboelastography 
(TEG) is recommended [4].
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Rotation thermoelectrometry (ROTEM
®
, TEM
®
 
Innovations, Munich, Germany) offers a recent 
alternative approach to assess perioperative 
coagulation disorders using the visco-elastic analysis 
of clotting. Trials specifically examining bleeding 
management in vascular surgery are lacking, and 
much of the literature and guideline are derived from 
studies on patients with trauma [5].
 
 
 
ROTEM® provides the most complete and 
rapid information on hemostasis.  
The ROTEM for the evaluation of fluid 
management during vascular surgery using either 
Albumin or Ringer lactate was adopted in this study.  
 
 
Methods 
 
After obtaining an approval from the 
departmental ethics and research committee of Cairo 
University hospitals (Kasr Alainy hospital) 60 patients 
aged (18-60 years) ASA physical status (I-III) 
undergoing vascular surgery were included in the 
study and randomly allocated into two groups using a 
random number generator, to receive either Human 
albumin or Ringer lactate after obtaining a written 
informed consent (Figure 1). 
 
Figure 1: CONSORT Flow Diagram 
 
After preoperative assessment and full 
medical history as well as laboratory investigations, 
patients were premedicated with 3 mg midazolam, 
and standard monitoring was applied. 
General anaesthesia was induced with 
Propofol (2 mg/kg), Rocuronium (0.6 mg/kg) and 
Fentanyl (2 µg/kg), followed by endotracheal 
intubation, isoflurane 1.5%. Mechanical ventilation 
was initiated using 50% oxygen in air through a 
closed-circuit system to keep SaO2 > 97% and end-
expiratory CO2 between 35 and 40 mm Hg.  
 Additional Fentanyl 50 mcg was given when 
heart rate or arterial blood pressure increased 20% 
above the baseline. Rocuronium top up was given as 
1/5 of the initial dose every 20 minutes.  
Fluid requirements were given based on fluid 
losses before the start of anaesthesia, maintenance 
requirements, normal fluid losses that occur during 
surgery, and response to unanticipated fluid (blood) 
loss.  
At the end of the surgical procedure, muscle 
relaxant was reversed with neostigmine 0.08 mg/kg 
and atropine 0.01 mg/kg. All patients were extubated 
and transferred to the postoperative care unit (PACU). 
 ROTEM is a modern modification of the TEG 
technology originally described by Hartert in 1948 [6], 
and it was used in the present study.  
These technologies provide a visual 
assessment of clot formation and subsequent lysis 
under low shear conditions (0.1/sec) similar to those 
present in the vena cava and well below those seen in 
venules, large veins, and the arterial system. Multiple 
test reagents are available for ROTEM; EXTEM 
(tissue factor activation), INTEM (ellagic 
acid/phospholipid activation). The commonly used 
ROTEM variables include clotting time (CT sec), clot 
formation time (CFT sec), α-angle (degree), maximum 
clot firmness (mm), and Lysis index (%). CT 
represents the onset of clotting, while CFT and α-
angle both represent the initial rate of fibrin 
polymerisation. MCF is a measure of the maximal 
viscoelastic strength of clot. Lysis index issued for the 
diagnosis of premature lysis or hyper-fibrinolysis.  
Enrolled patients were randomly allocated in 
two groups: 
Group A received 1-2 ml per minute of human 
albumin 5% combined with normal saline (0.9%).  
Group B received Ringer's lactate only as of 
the main solution. 
ROTEM variables, coagulation profile, and 
complete blood count were recorded for all patients’ 
pre-operative (baseline). ROTEM variables were 
measured after administration of fluids as 
postoperative measures.  
The amount of blood needed for testing was 4 
ml drawn before the operation and at the end of 
surgery with a citrate tube (blue tube) from the venous 
line or using a regular needle. The standard time of 15 
minutes was considered to begin processing. 
For ROTEM analysis, samples of blood were 
immediately mixed with 0.5 ml of a 3.2% citrate 
sodium solution (9 NC; Becton, Dickinson and Co., 
Franklin Lakes, NJ). After gentle mixing, the blood 
sample was analysed at 37°C. 
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The following ROTEM assays were 
performed, Ex-TEM which evaluates the extrinsic 
pathway, In-TEM evaluates the intrinsic pathway, and 
FIBTEM assess fibrinogen level after tissue. CT, CFT, 
ALP, MCF and ML parameters were measured in Ex-
TEM and In-TEM assays while only the MCF was 
reported in the FIBTEM. All ROTEM analyses were 
observed for 60 minutes and then stopped. 
Pain, vital signs, oxygen saturation, 
ventilation, and wound drainage were monitored 
during post-operative care. 
 
Statistical Analysis 
Data are presented as mean and standard 
deviation (SD). Non-normally distributed variables are 
expressed as median (25% and 75% percentiles). 
Non-parametric statistical tests were used for analysis 
if no normal distribution could be achieved by log 
transformation. 
Repeated Measures Analysis of covariance 
(ANCOVA) is used to test the statistical differences 
between ROTEM thromboelastometry 
All P-values are reported as results of two-
sided tests and values of P < 0.05 were considered 
statistically significant. 
 
 
Results 
 
Demographic data 
Patient characteristics including age and 
gender of both groups were comparable (Table 1). 
Table 1: Demographic variable 
Group Range Mean µ ± σ (95%)
a
 Between-Groups Effects, 
P-Value 
Age     
5% Human Serum 
Albumin 
21 – 53 40.87 36.53 - 45.20 P-Value (Fc) =0.475 
Ringers Lactate  21 - 60 43.07 38.73 - 47.40 
Gender Male Female  
5% Human Serum 
Albumin 
17 13 P Value (χ
2
) =0.2879 
Ringers Lactate 21 9 
a
 µ = Mean; σ = Standard Deviation. 
 
Regarding Surgical Wound Drainage: There 
was no statistically significant difference observed 
between both groups. Regarding haemoglobin level 
(Hb): No statistically significant difference was 
observed in Hb level between both groups. Regarding 
hematocrit level: No statistically significant difference 
was observed between both groups. Regarding 
coagulation profile: international normalised ratio 
(INR), prothrombin time (PT), and partial 
thromboplastin time (PTT). There was no statistically 
significant difference between both groups (Table 2). 
Table 2: Coagulation profile 
Parameter Mean µ ± σ (95%)
a
 Pairwise 
comparisons, 
P-Value 
Coagulation Profile    
    
 INR   
5% Human Serum Albumin 1.04 1.00 - 1.08 0.286 
Ringers Lactate  1.07 1.03 - 1.11  
    
 PT (seconds)   
5% Human Serum Albumin 12.80 12.39 - 13.21 0.302 
Ringers Lactate  12.50 12.09 - 12.91  
    
 aPPT(seconds)   
5% Human Serum Albumin 30.00 28.83 - 31.17 0.503 
Ringers Lactate  30.10 28.93 - 31.27  
  
a
 µ = Mean; σ = Standard Deviation. 
 
 
ROTEM thromboelastometry variables 
In-TEM variables 
In-TEM clotting time measured in seconds 
showed that there was no statistically significant 
difference was found between the two groups = 0.75. 
Within-group effects (the difference between baseline 
and postoperative regardless of the type of liquid) 
showed significant differences, P < 0.001. That 
revealed that both liquids have a significant impact on 
this parameter. The interaction between different 
effects and liquid effects showed significant 
differences, P < 0.001, (Figure 2).  
 
Figure 2: Clotting time, In-TEM 
 
In-TEM Clot Formation Time measured in 
seconds; there was no statistically significant 
difference between the two groups p = 0.77. Within-
group effects (the difference between baseline and 
postoperative regardless of the type of liquid) showed 
non-significant differences, P < 0.357. That revealed 
both liquids have a non-significant impact on this 
parameter. The interaction between different effects 
and liquid effects showed significant differences, P < 
0.001, (Figure 3).  
In-TEM Alpha Angel measured in degrees 
showed a statistically significant difference between 
the two groups, P < 0.001. Within-group effects (the 
difference between baseline and postoperative 
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regardless of the type of liquid) showed significant 
differences, P < 0.001.  
 
Figure 3: Clot Formation Time, In-TEM 
 
That revealed both liquids have a non-
significant impact on this parameter. The interaction 
between different effects and liquid effects showed 
significant differences, P < 0.001, (Figure 4).  
 
Figure 4: Alpha Angel, In-TEM 
 
In-TEM Maximum Clot Firmness measured in 
mm there was no statistically significant difference 
between the two groups P = 0.085. Within-group 
effects (the difference between baseline and 
postoperative regardless of the type of liquid) showed 
significant differences, P < 0.001. That revealed that 
both liquids have a significant impact on this 
parameter. The interaction between different effects 
and liquid effects showed significant differences, P < 
0.001, (Figure 5).  
 
 
 
Figure 5: Max Clot Firmness, In-TEM 
 
Ex-TEM variables 
Ex-TEM Clotting time values measured in 
seconds. There was a statistically significant 
difference between the two groups P < 0.001. Within-
group effects (the difference between baseline and 
postoperative regardless of the type of liquid) showed 
significant differences, P < 0.001. That revealed that 
both liquids have a significant impact on this 
parameter. The interaction between different effects 
and liquid effects showed significant differences, P < 
0.001, (Figure 6).  
 
Figure 6: Clotting Time, Ex-TEM 
 
Ex-TEM Clot Formation Time CFT values 
measured in seconds, Showed no statistically 
significant difference between the two groups P = 
0.104. Within-group effects (the difference between 
baseline and postoperative regardless of the type of 
liquid) showed significant differences, P < 0.008. That 
revealed that both liquids have a significant impact on 
this parameter. The interaction between different 
effects and liquid effects showed significant 
differences, P < 0.001 (Figure 7).  
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Figure 7: Clot Formation Time, Ex-TEM 
 
Ex-TEM Alpha Angel values measured in 
degree showed no statistically significant difference 
between the two groups P = 0.902. Within-group 
effects (the difference between baseline and 
postoperative regardless of the type of liquid) showed 
significant differences, P < 0.008. That revealed that 
both liquids have a significant impact on this 
parameter. The interaction between different effects 
and liquid effects showed non-significant differences, 
P = 0.208, (Figure 8). 
 
Figure 8: Alpha Angel, Ex-TEM 
 
Ex-TEM Maximum Clotting Firmness MCF 
values measured in mm, There was a statistically 
significant difference between the two groups P = 
0.045. Within-group effects (the difference between 
baseline and postoperative regardless of the type of 
liquid) showed significant differences, P < 0.001. That 
revealed that both liquids have a significant impact on 
this parameter. The interaction between different 
effects and liquid effects showed significant 
differences, P < 0.001 (Figure 9).  
 
 
 
Figure 9: Max Clot Firmness, Ex-TEM 
 
 
Discussion 
 
Maintenance of intravascular volume is 
important to achieve optimal perioperative outcomes. 
There is continuing debate regarding the quantity and 
the type of fluid resuscitation during elective major 
surgery [7].
 
 
In terms of the effect of albumin versus ringer 
lactate on blood loss, the results of this study were in 
line with published studies and meta-analyses 
comparing crystalloids and colloids for cardiac surgery 
[8]
 
postoperative bleeding often did not differ between 
crystalloids and colloids. Studies comparing albumin 
with non-protein colloids during cardiac surgery were 
in the majority in favour of albumin regarding 
transfusion requirements and mortality [9], [10], [11].
  
 
In contrast to this study, Johan AB 
Groeneveld found that Colloids are more efficient than 
crystalloids in attaining resuscitation endpoints since 
much less fluid volume is required [12].
  
Thromboelastography (TEG) and rotational 
thromboelastometry (ROTEM); are devices that 
provide the continuous measurement and display of 
the viscoelastic properties of a whole blood sample 
from the initial phase of ﬁbrin formation to clot 
retraction and ultimately ﬁbrinolysis [13].
 
 
Numerous studies have reported the 
utilisation of TEG and ROTEM as a monitoring device 
for hemostasis and transfusion management in 
various clinical settings, for example, cardiac surgery, 
liver transplantation, identification of patients with 
overt disseminated intravascular coagulation [14], 
hypercoagulability, and prediction thromboembolic 
events in surgical patients [15].  
Studies claim that TEG is a point of care 
device for rapid diagnosis and differentiation of 
hypercoagulable and hyperfibrinolytic conditions [16]. 
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TEG’s ability to assess hemostasis in whole 
blood renders it to be ideal for rapidly identifying 
patients with trauma-induced coagulation and 
transfusion guidance [17]. Rotation 
thromboelastometry (ROTEM
®
, TEM
®
 Innovations, 
Munich, Germany) offers an alternative approach to 
assess perioperative coagulation disorders using the 
visco-elastic analysis of clotting in vitro. First results 
are available within 10 min of test initiation, and clot 
formation can be observed online by a bedside 
monitor. ROTEM
®
 measurements of EXTEM and 
INTEM are reproducible and stable over time, 
regardless of a delay from blood withdrawal to 
analysis (range 0–120 min after blood withdrawal). 
Along with this present study, some studies 
report TEG and ROTEM to be a useful research tool 
in comparison to six common tests, hematocrit, 
platelet count, fibrinogen, PT, aPTT, and fibrin split 
degradation [18], suggesting a strong relationship. 
Tripodi and colleagues [19]
 
stated that 
standard coagulation tests failed to reflect the balance 
between the actions of pro- and anticoagulant factors. 
By this study, Wang and colleagues [20] 
showed a significant decrease in transfused 
allogeneic blood products following a transfusion 
algorithm using ROTEM
®
 compared with standard 
laboratory tests in liver transplant surgery.  
Data from Schöchl and colleagues revealed 
the effective use of ROTEM
®
-guided coagulation 
management in trauma patients by reducing the 
amount of allogeneic blood product transfusion [21].
  
Koray et al. have demonstrated that a 
ROTEM®-based coagulation algorithm decreased 
total transfusion costs in cardiac surgery which is 
consistent with results of the current study [22]. 
In line with this study, a previous 
thrombelastographic study in patients undergoing 
knee replacement surgery and exhibiting even minor 
blood loss and intravascular volume replacement 
already showed that colloid administration reduces 
final clot strength more than Ringer lactate solution 
does [23]. 
Limitations: 1. Although ROTEM
®
 can guide 
the clinician as to which type of treatment may be 
most helpful to treat coagulopathy during surgery or in 
trauma ROTEM
®
 results cannot give exact 
recommendations on the number of blood products or 
coagulation factors to be administered; 2. 
Thromboelastometry/Thromboelastography is a 
valuable addition to the diagnostics of perioperative 
coagulation management, but it should not be 
overlooked that this method by no means provides a 
complete picture of clotting SO as to avoid this 
drawback correlation between thrombo-elastographic 
coagulation time and conventional PT and PTT should 
be considered; 3. Thromboelastography should be 
performed by trained personnel, and its technique 
requires standardisation. Standard parameters of 
ROTEM do not directly examine platelet function; 
recently specific “platelet mapping assay” for ROTEM 
had been introduced to practice; 4. ROTEM
®
 analyses 
were performed not as bedside tests but in a central 
laboratory with a certain time delay for sample 
transport. 
This study concluded that the use of human 
albumin (5%) in vascular surgeries before reaching 
the trigger point for blood transfusion didn’t improve 
blood loss or coagulation profile compared to the use 
of ringer lactate only. Therefore, ringer lactate can be 
used as a good replacement for human albumin. 
Ringer lactate is readily available and inexpensive 
while human albumin may be costly. 
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